Investing Port

P/S	52.84
P/BV	18.33
EV/EBITDA	-126.39
EBITDA	-0.06
Цена ао	167.5

Дата сделки	Дата раскрытия	Инсайдер	Тип	Цена	Объем	Количество	Доля до, %	Доля после, %	Документ
23.12.2020	28.12.2020	McAnear Justin J. Chief Financial Officer	Покупка	5.04	99 999.00	19841	0	0.1	ссылка
24.12.2020	28.12.2020	Hindson Benjamin J. See Remarks	Покупка	1.12	41 032.00	36636	0	0.19	ссылка

Institutions	Объем	Доля, %
First Trust Portfolios L.P.	48116	0.07
Pzena Investment Management Inc	137932	0.2
Brandywine Global Investment Mgmt, LLC	57027	0.08
Guggenheim Funds Distributors, LLC	25	0
PPM America, Inc.	418900	0.6
Invesco Capital Markets Inc	30	0
ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg	527007	0.76
Fuller & Thaler Asset Mgmt	10209921	14.73
Invesco Capital Management LLC	196190	0.28
Jackson National Asset Management LLC	914729	1.32
Hennion & Walsh, Inc	200	0
Sparinvest S.A.	198949	0.29
Pacific Life Fund Advisors LLC (PLFA)	202709	0.29
Security Investors, LLC	34175	0.05
Sabrient Systems	10646	0.02
UBS Asset Management (Americas) Inc	164258	0.24
Fisher Investments CA	77036	0.11
TCW Investment Management Co LLC	83636	0.12
Federated Hermes, Inc.	101921	0.15
Nationwide Fund Advisors	213474	0.31

ETF	Доля, %	Доходность за год, %
Vanguard Small Cap Value ETF	0.45	13.19
Schwab U.S. Small-Cap ETF	0.31	28.09
Principal Healthcare Innovators Index ETF	1.36	55.27
US Global GO GOLD and Precious Metal Miners ETF	3.87	22.35
Renaissance IPO ETF	2.36	111.77
Entrepreneur 30 Fund	3.01	53.60
AI Powered International Equity ETF	1.47	19.23
Sprott Gold Miners ETF	3.33	25.45
Sprott Junior Gold Miners ETF	3.27	50.01

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. Its company offers chromium instruments, enzymes, microfluidic chips, slides, reagents, and other consumable products. The company's single cell solution runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics, including the physical organization of DNA; single cell CNV for measuring cellular heterogeneity through DNA changes, such as copy number variation; and visium spatial gene expression solution that measures the spatial gene expression patterns across a tissue sample. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. 10x Genomics, Inc. was founded in 2012 and is headquartered in Pleasanton, California.